SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Jack Russell who wrote (11919)5/13/2013 11:58:30 AM
From: pincus1 Recommendation  Read Replies (1) | Respond to of 13111
 
Well, not that I am accusing anyone of anything, but the people at the Yahoo board seem to have a grasp on exactly who NTTG is--even a name. If what they say is correct, it follows that NTTG has reasons for being so publicly obsessive about this rather humble stock. As they say, suddenly the world makes sense.



To: Jack Russell who wrote (11919)5/13/2013 1:24:18 PM
From: NTTG1 Recommendation  Read Replies (2) | Respond to of 13111
 
Do you think it is appropriate for PVCT to not be at ASCO on the cusp of their phase III trial...very simple question Jack yes/no....why dodge the issue at hand?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News